MYC and lymphoma: Furthermore, ATF4 ablation significantly reduces in vitro clonogenic survival of MEFs with high c‐Myc level and extends tumor‐free and overall survival in syngeneic mouse model of lymphoma with hyperactive c‐Myc (Tameire et al, 2019).